Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by sunny3999on Jan 21, 2018 2:13pm

872 Views

Post# 27403907

RE:Updated figures 2018-2021: Revenue/EBITDA/Forward Earnings

Link to Wallstreet Online postings:

Link: By the way we reached 2943 members in our "Cannabis Aktien Forum and News"

And we reached a kind of internationality:
User image

sunny3999 wrote:
As i was asked after posting Chartguys outlook for the next week about future revenues and longterm view on Wallstreet Online.

Here is my summary and extrapolation of all new Purchases from Aphria with participation in DOJA / Broken Coast (without some other Partnerstakes like Tetra Biopharma, Scythian Bioscience, CannaRoyalty a.s,o).

Let's see if we actually make this development this year in 2018, then I see rather lower hurdles, since then all licenses with expansion and internationality and an almost mainstream (broad mass) cannabis globalization should be reached - at least in North America so Canada & USA and certainly also Europe!

Sure, the Aphria management with their Partners will raise the bar with every news, but also the real sales and estimated profit margins with EBITDA have to be achieved - at least as a trend!